ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,546,782, issued on Feb. 10, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.).
"Identification and monitoring of monoclonal immunoglobulins related to monoclonal gammopathy by molecular mass with mass spectrometry" was invented by David R. Barnidge (Rochester, Minn.) and David L. Murray (Rochester, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosure herein are methods for determining whether or not an immunoglobulin is present above the polyclonal background level in a biological sample, and methods for determining whether an immunoglobulin contains a kappa or lambda light chain. These methods are useful f...